Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs

TrAC - Trends in Analytical Chemistry

Volumn 28, Issue 1, 2009, Pages 13-28

  Singh, Saranjit ^a   Prasad, Bhagwat ^a   Savaliya, Akash A ^a   Shah, Ravi P ^a   Gohil, Vikrantsinh M ^a   Kaur, Amandeep ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Adulteration; Analogue; Counterfeit; Detection; Herbal dietary supplement; PDE 5 inhibitor; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

ADULTERATION; ANALOGUE; COUNTERFEIT; DETECTION; HERBAL DIETARY SUPPLEMENT; PDE-5 INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

AIRCRAFT ENGINES; CHROMATOGRAPHIC ANALYSIS; DECISION MAKING; DECISION THEORY; DECISION TREES; FOOD ADDITIVES; FOURIER TRANSFORMS; GRAPHIC METHODS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUTRITION; PARTIAL DIFFERENTIAL EQUATIONS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; VITAMINS;

INFRARED SPECTROSCOPY;

ACETILDENAFIL; AMINOTADALAFIL; BENZAMIDENAFIL; DRUG ANALOG; HERBACEOUS AGENT; HOMOSILDENAFIL; HYDROXYHOMOSILDENAFIL; METHISOSILDENAFIL; PIPERIDENAFIL; PIPERIDINO VARDENAFIL; RHINO V MAX; SILDENAFIL; TADALAFIL; THIOHOMOSILDDENAFIL; THIOSILDENAFIL; UNCLASSIFIED DRUG; V MAX; VARDENAFIL; ZENCORE;

ARTICLE; CHINESE MEDICINE; DIET SUPPLEMENTATION; DRUG APPROVAL; DRUG CONTAMINATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG MARKETING; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROMETRY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NEAR INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

EID: 58149279469     PISSN: 01659936     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trac.2008.09.004     Document Type: Article

References (55)

1. Rang H.P., Dale M.M., Ritter J.M., and Moore P.K. Pharmacology. Fifth ed. (2003), Elsevier, New Delhi, India
2. Corbin J.D., and Francis S.H. J. Androl. 24 (2003) S38
3. Kloner R. Int. J. Impot. Res. 19 (2007) 296
4. Huang W.F., Wen K.C., and Hsiao M.L. J. Clin. Pharmacol. 37 (1997) 344
5. Koh H.L., and Woo S.O. Drug Safety 23 (2000) 351
6. Ko R.J. N. Engl. J. Med. 339 (1998) 847
7. Au A.M., Ko R., Boo F.O., Hsu R., Perez G., and Yang Z. Bull. Environ. Contam. Toxicol. 65 (2000) 112
8. Miller G.M., and Stripp R. Leg. Med. (Tokyo) 9 (2007) 258
9. US Food and Drug Administration, Press Release, 2000.
10. US Food and Drug Administration, Press Release, 2001.
11. Anon, Curr. Problems Pharmacovigilance 27 (2001).
12. Cuncha J., Pereira L., Pun M.I., Lopes V., and Vong S.K. Hong Kong Pharm. J. 7 (1998) 50
13. Kew J., Morris C., Aihie A., Fysh R., Jones S., and Brooks D. Br. Med. J. 306 (1993) 506
14. Lau K.K., Lai C.K., and Chan A.W. Hum. Exp. Toxicol. 19 (2000) 385
15. Schaumburg H.H., and Berger A. JAMA 268 (1992) 3430
16. Sheerin N.S., Monk P.N., Aslam M., and Thurston H. Br. J. Clin. Pract. 48 (1994) 332
17. Wu M.S., Hong J.J., Lin J.L., Yang C.W., and Chien H.C. Nephrol. Dial. Transplant. 11 (1996) 867
18. Shin M.H., Hong M.K., Kim W.S., Lee Y.J., and Jeoung Y.C. Food Addit. Contam. 20 (2003) 793
19. Blok-Tip L., Zomer B., Bakker F., Hartog K.D., Hamzink M., Ten Hove J., Vredenbregt M., and De Kaste D. Food Addit. Contam. 21 (2004) 737
20. Poon W.T., Lam Y.H., Lai C.K., Chan A.Y., and Mak T.W. Hong Kong Med. J. 13 (2007) 359
21. Reepmeyer J.C., and Woodruff J.T. J. Pharm. Biomed. Anal. 44 (2007) 887
22. Zou P., Oh S.S., Hou P., Low M.Y., and Koh H.L. J. Chromatogr., A 1104 (2006) 113
23. Oh S.S., Zou P., Low M.Y., Koh H.L., and Toxicol J. Environ. Health, A 69 (2006) 1951
24. Hou P., Zou P., Low M.Y., Chan E., and Koh H.L. Food Addit. Contam. 23 (2006) 870
25. Zou P., Hou P., Oh S.S.-Y., Chong Y.M., Bloodworth B.C., Low M.-Y., and Koh H.-L. J. Pharm. Biomed. Anal. 47 (2008) 279
26. Lam Y.H., Poon W.T., Lai C.K., Chan A.Y., and Mak T.W. J. Pharm. Biomed. Anal. 46 (2008) 804
27. http://www.fda.gov/oc/po/firmrecalls/cosmos03_07.html (Accessed on: 23.04.2008).
28. http://www.fda.gov/oc/po/firmrecalls/bodee08_07.html (Accessed on: 23.04.2008).
29. http://www.fda.gov/oc/po/firmrecalls/barodon03_07.html (Accessed on: 23.04.2008).
30. http://www.fda.gov/oc/po/firmrecalls/twcglobal09_07.html (Accessed on: 23.04.2008).
31. http://www.fda.gov/bbs/topics/news/2007/NEW01737.html (Accessed on: 23.04.2008).
32. Reepmeyer J.C., Woodruff J.T., and d'Avignon D.A. J. Pharm. Biomed. Anal. 43 (2007) 1615
33. Gratz S.R., Flurer C.L., and Wolnik K.A. J. Pharm. Biomed. Anal. 36 (2004) 525
34. Lai K.C., Liu Y.C., Tseng M.C., and Lin J.H. J. Food Drug Anal. 14 (2006) 19
35. Mei C.L., Yi C.L., and Jer H.L. J. Food Drug Anal. 14 (2006) 260
36. Gratz S.R., Gamble B.M., and Flurer R.A. Rapid Commun. Mass Spectrom. 20 (2006) 2317
37. Reepmeyer J.C., and Woodruff J.T. J. Chromatogr., A 1125 (2006) 67
38. Liang Q., Qu J., Luo G., and Wang Y. J. Pharm. Biomed. Anal. 40 (2006) 305
39. Venhuis B.J., Blok-Tip L., and de Kaste D. Forensic Sci. Int. 177 (2008) e25
40. Venhuis B.J., Zomer G., and de Kaste D. J. Pharm. Biomed. Anal. 46 (2008) 814
41. Zou P., Hou P., Oh S.S.Y., Ge X., Bloodworth B.C., Low M.Y., and Koh H.L. J. Pharm. Biomed. Anal. 47 (2008) 255
42. Bogusz M.J., Hassan H., Al-Enazi E., Ibrahim Z., and Al-Tufail M. J. Pharm. Biomed. Anal. 41 (2006) 554
43. Wong S.K., Tsui S.K., and Kwan S.Y. J. Pharm. Biomed. Anal. 30 (2002) 161
44. Moriyasu T., Shigeoka S., Kishimoto K., Ishikawa F., Nakajima J., Kamimura H., and Yasuda I. Yakugaku Zasshi 121 (2001) 765
45. Reddy T.S., Reddy A.S., and Devi P.S. J. Planar Chromatogr. Mod. TLC 19 (2006) 427
46. Choi D.M., Park S., Yoon T.H., Jeong H.K., Pyo J.S., Park J., Kim D., and Kwon S.W. J. AOAC Int. 91 (2008) 580
47. Venhuis B.J., Barends D.M., Zwaagstra M.E., and Kaste D.D. RIVM Report 370030001 (2007)
48. Maurin J.K., Plucinski F., Mazurek A.P., and Fijałek Z. J. Pharm. Biomed. Anal. 43 (2007) 1514
49. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., and Kaste D.D. J. Pharm. Biomed. Anal. 40 (2006) 840
50. Veij M.D., Deneckere A., Vandenabeele P., Kaste D.D., and Moens L. J. Pharm. Biomed. Anal. 46 (2008) 303
51. Trefi S., Routaboul C., Hamieh S., Gilard V., Malet-Martino M., and Martino R. J. Pharm. Biomed. Anal. 47 (2008) 103
52. http://www.who.int/medicines/services/counterfeit/overview/en/ (Accessed on: 07.07.2008).
53. Chem G., Wang H., Robinson H., Cai J., Wan Y., and Ke H. Biochem. Pharmacol. 75 (2008) 1717
54. Bayer-Aktiengesellschaft, WO99/67244 (1999).
55. Lilly-ICOS-LLC, WO02/098428 (2002).